Odevixibat for treating progressive familial intrahepatic cholestasis (HST17)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 22 February 2022
MRI-based technologies for assessing non-alcoholic fatty liver diseaseStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: 15 December 2022
Cirrhosis in over 16s: assessment and managementStatus:In developmentProgramme:NICE guidelineExpected publication date: 7 February 2024
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
OrganOx metra for liver transplant [ID5116]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC